Literature DB >> 22814825

High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy.

Sinead McEvoy1, Lisa Lavelle, Aoife Kilcoyne, Colin McCarthy, Pim A deJong, Martine Loeve, Harm A W M Tiddens, Edward McKone, Charles G Gallagher, Jonathan D Dodd.   

Abstract

OBJECTIVES: To determine the diagnostic accuracy of high-resolution computed tomography (HRCT) for the detection of nontuberculous mycobacterium infection (NTM) in adult cystic fibrosis (CF) patients.
METHODS: Twenty-seven CF patients with sputum-culture-proven NTM (NTM+) underwent HRCT. An age, gender and spirometrically matched group of 27 CF patients without NTM (NTM-) was included as controls. Images were randomly and blindly analysed by two readers in consensus and scored using a modified Bhalla scoring system.
RESULTS: Significant differences were seen between NTM (+) and NTM (-) patients in the severity of the bronchiectasis subscore [45 % (1.8/4) vs. 35 % (1.4/4), P = 0.029], collapse/consolidation subscore [33 % (1.3/3 vs. 15 % (0.6/3)], tree-in-bud/centrilobular nodules subscore [43 % (1.7/3) vs. 25 % (1.0/3), P = 0.002] and the total CT score [56 % (18.4/33) vs. 46 % (15.2/33), P = 0.002]. Binary logistic regression revealed BMI, peribronchial thickening, collapse/consolidation and tree-in-bud/centrilobular nodules to be predictors of NTM status (R(2 )= 0.43). Receiver-operator curve analysis of the regression model showed an area under the curve of 0.89, P < 0.0001.
CONCLUSION: In adults with CF, seven or more bronchopulmonary segments showing tree-in-bud/centrilobular nodules on HRCT is highly suggestive of NTM colonisation. KEY POINTS: Lung function declines rapidly in cystic fibrosis patients with nontuberculous mycobacterium infection. High-resolution computed tomography can help identify nontuberculous mycobacterium in CF patients. Extensive collapse/consolidation and tree-in-bud/centrilobular nodules are predictive of NTM infection. Multiple bronchopulmonary segments showing tree-in-bud/centrilobular nodules strongly suggest nontuberculous mycobacterium infection.

Entities:  

Mesh:

Year:  2012        PMID: 22814825     DOI: 10.1007/s00330-012-2558-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

2.  Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease.

Authors:  E Tanaka; R Amitani; A Niimi; K Suzuki; T Murayama; F Kuze
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

3.  Changes in airway dimensions on computed tomography scans of children with cystic fibrosis.

Authors:  Pim A de Jong; Yasutaka Nakano; Wim C Hop; Frederick R Long; Harvey O Coxson; Peter D Paré; Harm A Tiddens
Journal:  Am J Respir Crit Care Med       Date:  2005-04-14       Impact factor: 21.405

4.  Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation.

Authors:  Tae Sung Kim; Won-Jung Koh; Joungho Han; Myung Jin Chung; Ju Hyun Lee; Kyung Soo Lee; O Jung Kwon
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 5.  Nontuberculous mycobacteria in the setting of cystic fibrosis.

Authors:  Deborah L Ebert; Kenneth N Olivier
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

6.  Nontuberculous mycobacterial infection in young children with cystic fibrosis.

Authors:  Charles R Esther; Marianna M Henry; Paul L Molina; Margaret W Leigh
Journal:  Pediatr Pulmonol       Date:  2005-07

7.  Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.

Authors:  Eoin P Judge; Jonathan D Dodd; James B Masterson; Charles G Gallagher
Journal:  Chest       Date:  2006-11       Impact factor: 9.410

8.  Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: comparison between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus infection.

Authors:  Myung Jin Chung; Kyung Soo Lee; Won-Jung Koh; Ju Hyun Lee; Tae Sung Kim; O Jung Kwon; Seonwoo Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

9.  Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis.

Authors:  P A de Jong; Y Nakano; M H Lequin; J R Mayo; R Woods; P D Paré; H A W M Tiddens
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

10.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

View more
  2 in total

1.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

2.  Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates.

Authors:  Andrew J Ghio; Genee S Smith; Stephanie DeFlorio-Barker; Kyle P Messier; Edward Hudgens; Mark S Murphy; Jean-Marie Maillard; Jason E Stout; Elizabeth D Hilborn
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.